Janus Henderson European Growth I

Targets capital growth from large and mid-cap continental European equities.

  • 652.40p
    Price (Inc)

    These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.

  • -
    Price (Acc)

    These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?

  • 0.00%

    Initial charge

    Some funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!

  • 0.75%
    Annual management charge

    This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).

  • 0.84%
    Ongoing charges

    This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.

  • 1.20%

    How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…

Prices as at 07 May 2021, fund data last updated 12 March 2014

The Fund seeks long-term capital growth principally through investment in large and medium sized continental European companies.

Fund summary

Sector Europe Excluding UK
Structure OEIC
Launched July, 2001
Size £0m
Yield 1.20%
Charging basis Income
Dividends paid Acc units only


Standard initial charge 0.00%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.00%
Annual management charge 0.75%
Ongoing charges figure 0.84%


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}

Investment process

Manager research

Average monthly relative returns

  • 16/17 0.00%
  • 17/18 0.00%
  • 18/19 -0.24%
  • 19/20 -0.10%
  • 20/21 0.02%

Bestinvest MRI

  • 3 years -0.11%
  • 5 years 0.00%
  • Career -0.11%
  • 3 years 42.10%
  • 5 years 0.00%
  • Career 40.90%

Performance figures are based on the average of monthly percentage returns relative to the benchmark index.

Marc Schartz / Simon Rowe

Schartz is a Portfolio Manager of European equities at Janus Henderson Investors, a position he has held since 2017. He joined Henderson in 2016 as an analyst. Prior to this, he was with GO Investment Partners, where he was involved in the active management of a concentrated portfolio in the European small- and mid-cap space. Before that, he was on the investment team of Fortis Private Bank Luxembourg. Schartz received an MSc in banking and international finance from City, University of London, Cass Business School. He holds the Chartered Financial Analyst designation. Rowe joined Henderson in 2009 from New Star Asset Management where he was Fund Manager for European Equities. Rowe started his career in journalism as a staff writer for Investor Chronicle. He graduated from Cambridge where he attained a BA in History.

Track record

Marc Schartz / Simon Rowe has 3.4 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been -0.11%. During the worst period of relative performance (from February 2018 - February 2020) there was a decline of 8% relative to the index. The worst absolute loss has been 19%.

Periods of worst performance

Absolute -19.00% (July 2019 - March 2020)
Relative -8.00% (February 2018 - February 2020)

About the MRI

Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}

Top 10 holdings

Data accurate as at 31 July 2020

3.7993% Nestle Sa
3.1361% Novo-Nordisk As
3.0576% Carlsberg
2.9704% Akzo Nobel Nv
2.9282% Bayer Ag
2.758% Sanofi
2.7426% Roche Hldg Ag
2.6968% Asr Nederland Nv
2.5188% Sampo Corp
2.4457% Dcc
Source: Trustnet

Sector breakdown

Biotechnology/Medical 15.00%
Chemicals 8.00%
Industrials 8.00%
Support Services 6.00%
Food Producers 5.00%
Software 5.00%
Insurance 5.00%
Media 5.00%
Banks 5.00%
Hardware 5.00%

Key Investor Information